Sign In
Buy NMTR
$0.0722
+0 (+0%)
At Close: Nov 20, 2023
9 Meters Biopharma, Inc. Appoints Michael T. Constantino to Board of Directors
08:15pm, Monday, 06'th Jul 2020
RALEIGH, NC / ACCESSWIRE / July 6, 2020 / 9 Meters Biopharma, Inc. (NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced today the Company has appointed Michael T.
9 Meters Biopharma, Inc. to Participate in BMO Capital Markets' "Hidden Gems in Healthcare Conference Call Series"
11:30am, Thursday, 02'nd Jul 2020
Conference Call Scheduled for July 9, 2020 RALEIGH, NC / ACCESSWIRE / July 2, 2020 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, tod
9 Meters Biopharma, Inc. Amends Definition of Primary Endpoint for Phase 3 Trial in Celiac Disease After Consultation with FDA
11:30am, Monday, 29'th Jun 2020
RALEIGH, NC / ACCESSWIRE / June 29, 2020 / 9 Meters Biopharma, Inc. (NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, today announced that, after consultation with the FD
9 Meters Biopharma, Inc. Initiates Phase 1b/2a Clinical Trial in Short Bowel Syndrome
08:05pm, Wednesday, 24'th Jun 2020
RALEIGH, NC / ACCESSWIRE / June 24, 2020 / 9 Meters Biopharma, Inc. (NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, today announced it has initiated its Phase 1b/2a cli
9 Meters Biopharma, Inc Receives Thorough QT Study Waiver by FDA for Larazotide Being Studied for Celiac Disease
11:00am, Monday, 11'th May 2020
RALEIGH, NC / ACCESSWIRE / May 11, 2020 / 9 Meters Biopharma, Inc (NMTR), today announced that it has received a thorough QT (TQT) study waiver as requested by the Company from the US Food and Drug Ad
9 Meters Biopharma, Inc Announces the Closing of Naia Rare Diseases Acquisition
11:00am, Thursday, 07'th May 2020
RALEIGH, NC / ACCESSWIRE / May 7, 2020 / 9 Meters Biopharma, Inc (NASDAQ:NMTR), today announced that it has closed the merger with Naia Rare Diseases, a company developing a proprietary long-acting gl
9 Meters Biopharma Hosting Research and Development Day
10:30am, Tuesday, 05'th May 2020
RALEIGH, NC / ACCESSWIRE / May 5, 2020 / 9 Meters Biopharma (NASDAQ:NMTR), a clinical-stage gastroenterology company focused on specialty, rare, and orphan diseases, today announced that it will host
9 Meters Biopharma, Inc Announces the Closing of $22.5 Million Private Placement Funding
09:30pm, Monday, 04'th May 2020
RALEIGH, NC / ACCESSWIRE / May 4, 2020 / 9 Meters Biopharma, Inc (NASDAQ:NMTR), today announced that it has closed a private placement with existing and new investors to raise $22.5 million. The priv
